Case Study  ·  Technology Landscape

Finding the next move in oncology.

A global pharmaceutical leader wanted opportunities to strengthen its oncology pipeline. We studied cancer vaccines, KRAS and liquid biopsies in turn, building a landscape for each and then testing hypotheses with experts.

The Client

The client is a global leader in the pharmaceutical industry with a strong oncology pipeline. It wanted opportunities that would add to that pipeline and could also stand on their own.

The Challenge

Three hot fields.
Find the real openings.

Prescouter was asked to explore opportunities that could enhance the client’s oncology pipeline or stand alone, focusing in turn on cancer vaccines, KRAS and liquid biopsies.

  • Vaccines

    Cancer vaccine platforms

    Early advances in vaccine design.

  • Targets

    The KRAS landscape

    A closely watched oncology target.

  • Diagnostics

    Liquid biopsies

    Detecting cancer from a blood sample.

Our Approach

Landscapes first, then hypothesis testing.

Landscape build
3focus areas studied

Map each field

We combined secondary research with expert discussions to chart each space and spot openings.

Literature review
200publications and technologies

Read the science

We analyzed early-stage publications and technologies to see where innovation is moving.

Hypothesis testing
6vaccine platforms flagged

Test the leads

More expert interviews and research answered the key questions in each topic area.

The Outcome

Six platforms worth a closer look.

Prescouter analyzed 200 publications and early-stage technologies and identified the 6 most promising cancer vaccine platforms. The work also explored novel tertiary lymphoid structures, giving the client a clear view of early oncology innovation to guide pipeline decisions.

  • Evidence

    200 sources analyzed

    Publications and early-stage technologies.

  • Platforms

    6 cancer vaccine platforms

    The most promising in the field.

  • Frontier

    Tertiary lymphoid structures

    An emerging area worth watching.

Early science moves faster than pipelines. Mapping it field by field helps teams act before the opportunities get crowded.

Let’s Talk

Which oncology bets could strengthen your pipeline?

Map the science, test the hypotheses and focus on the platforms that matter. Wherever you’re starting from, we’ll help you get there.

Or email [email protected]

Book a Session

Want to skip the email back-and-forth?

Pick a time on our calendar right now.

If you’d like to know the outcome of your submission, please leave your email address